References
Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Saf 2000 Jan; 22(1): 53–72
Job ML, Jacobs NF. Drug-induced Clostridium difficile-associated disease. Drug Saf 1997; 17: 37–46
Nawaz A, Mohammed I, Ahsan K, et al. Clostridium difficile colitis associated with treatment of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 1175–6
Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995; 38: 350–4
Kaufmann MJS, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987; 107: 513–6
Spreux A, Rodriguez A, Chichmanian RM. Case reports on drug-induced chronic diarrhea. An often unrecognised etiology? Therapie 1993; 48: 494–5
Bennett RG, Greenough WB. Approach to acute diarrhea in the elderly. Gastroenterol Clin North Am 1993; 22: 517–33
Talal AH, Murray JA. Acute and chronic diarrhea. How to keep laboratory testing to a minimum. Postgrad Med 1994; 96: 30–8
Fine KD. Diarrhea. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: WB Saunders, 1998: 128–52
Wenisch C, Parschalk B, Hasenhundl M, et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22: 813–8
Hospital Infection Control Advisory Committee. Recommendations for preventing the spread of vancomycin-resistant enterococci. Am J Infect Control 1995; 23: 87-94
Fekety R, McFarland LV, Surawicz CM, et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24: 324–33
Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739–50
Rights and permissions
About this article
Cite this article
Drug-induced diarrhoea: a far from rare adverse event. Drugs Ther. Perspect 17, 9–12 (2001). https://doi.org/10.2165/00042310-200117010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117010-00003